Prevalence of BRCA1 and BRCA2 mutations in ovarian cancer patients from the French-Canadian population.

被引：0
|
作者：
Guenard, F
Klappenberger, S
Labrie, Y
Plante, M
Tetu, B
Durocher, F
机构：
[1] CHUL, Res Ctr, Canc Genom Lab, Quebec City, PQ, Canada
[2] Hop Hotel Dieu, Dept Oncol, Ctr Rech, Quebec City, PQ, Canada
[3] Hop Hotel Dieu, Dept Pathol, Ctr Rech, Quebec City, PQ, Canada
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 2002年 / 71卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
355
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [21] Prevalence of BRCA1 and BRCA 2 and other mutations in Chilean population.
    Selman, Carolina
    Hurtado, Mabel
    Chahuan, Badir
    Mella, Fabiola
    Marsiglia, Hugo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary
    Van der Looij, M
    Szabo, C
    Besznyak, I
    Liszka, G
    Csokay, B
    Pulay, T
    Toth, J
    Devilee, P
    King, MC
    Olah, E
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2000, 86 (05) : 737 - 740
  • [23] Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer
    Paik, E. Sun
    Heo, Eun Jin
    Choi, Chel Hun
    Kim, Jae-Hoon
    Kim, Jae-Weon
    Kim, Yong-Man
    Park, Sang-Yoon
    Lee, Jeong-Won
    Kim, Jong-Won
    Kim, Byoung-Gie
    [J]. CANCER SCIENCE, 2021, 112 (12) : 5055 - 5067
  • [24] Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer
    Risch, HA
    McLaughlin, JR
    Cole, DEC
    Rosen, B
    Bradley, L
    Kwan, E
    Jack, E
    Vesprini, DJ
    Kuperstein, G
    Abrahamson, JLA
    Fan, I
    Wong, B
    Narod, SA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) : 700 - 710
  • [25] Clinical and pathologic characteristics of ovarian cancer patients with BRCA1 and BRCA2 mutations in Turkish population
    Saip, Pinar
    Akdeniz, Bernet
    Tuncer, Bugra
    Kilic, Sada
    Sukruoglu, Olga
    Altundag, Keyser
    Kilic, Leyla
    Ciftcl, Rumeysa
    Yazicl, Hulya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Screening for BRCA1 and BRCA2 mutations among French-Canadian breast cancer cases attending an outpatient clinic in Montreal
    Ghadirian, P.
    Robidoux, A.
    Nassif, E.
    Martin, G.
    Potvin, C.
    Patocskai, E.
    Younan, R.
    Larouche, N.
    Venne, A.
    Zhang, S.
    Royer, R.
    Narod, S. A.
    [J]. CLINICAL GENETICS, 2014, 85 (01) : 31 - 35
  • [27] Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations
    Ganguly, Shuvadeep
    Gogia, Ajay
    [J]. LANCET ONCOLOGY, 2022, 23 (07): : E314 - E314
  • [28] Unwrapping the Implications of BRCA1 and BRCA2 Mutations in Ovarian Cancer
    Hyman, David M.
    Spriggs, David R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 408 - 410
  • [29] Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer
    Ramus, Susan J.
    Harrington, Patricia A.
    Pye, Carole
    DiCioccio, Richard A.
    Cox, Mark J.
    Garlinghouse-Jones, Kim
    Oakley-Girvan, Ingrid
    Jacobs, Ian J.
    Hardy, Richard M.
    Whittemore, Alice S.
    Ponder, Bruce A. J.
    Piver, M. Steven
    Pharoah, Paul D. P.
    Gayther, Simon A.
    [J]. HUMAN MUTATION, 2007, 28 (12) : 1207 - 1215
  • [30] Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
    Abugattas, J.
    Llacuachaqui, M.
    Allende, Y. Sullcahuaman
    Velasquez, A. Arias
    Velarde, R.
    Cotrina, J.
    Garces, M.
    Leon, M.
    Calderon, G.
    de la Cruz, M.
    Mora, P.
    Royer, R.
    Herzog, J.
    Weitzel, J. N.
    Narod, S. A.
    [J]. CLINICAL GENETICS, 2015, 88 (04) : 371 - 375
12345